Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedUpdate to revision from v3.1.0 to v3.2.0 and add a government funding operating-status notice; remove a specific resource listing (Classic familial adenomatous polyposis).SummaryDifference5%

- Check34 days agoChange Detected- Added Revision: v3.1.0. - Removed several drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a possible scope reduction or reorganization in favor of the new version label.SummaryDifference0.5%

- Check48 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. This is a small, non-critical update with no changes to core content or key data.SummaryDifference0.3%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check62 days agoChange DetectedThe web page has added significant resources related to genetic and rare diseases, including specific topics on colonic polyps and various amino acids, while removing outdated information about familial adenomatous polyposis and other related diseases.SummaryDifference12%

- Check77 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.